Ganaxolone, an approved therapy for CDKL5-Deficiency Disorder, is an inhibitor of PTP1B
Imanol Zubiete‐Franco(CIC bioGUNE), N. K. Tonks(Cold Spring Harbor Laboratory)
Cited by 0
Related Papers
SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer
|EBioMedicine|2018|79
Famotidine increases cellular phospho-tyrosine levels
|Biochemical and Biophysical Research Communications|2024|2